Results 61 to 70 of about 172 (123)

Design of Radioiodinated Pharmaceuticals: Structural Features Affecting Metabolic Stability towards in Vivo Deiodination. [PDF]

open access: yesEuropean J Org Chem, 2017
Cavina L   +5 more
europepmc   +1 more source

A novel radioiodination reagent for protein radiopharmaceuticals with L- lysine as a plasma-stable metabolizable linkage to liberate m-iodohippuric acid after lysosomal proteolysis

open access: yesA novel radioiodination reagent for protein radiopharmaceuticals with L- lysine as a plasma-stable metabolizable linkage to liberate m-iodohippuric acid after lysosomal proteolysis
Radiochemical design of polypeptides using metabolizable linkages would be attractive to enhance target-selective localization of radioactivity for diagnostic and therapeutic nuclear medicine. However, while use of ester bonds as the linkage allows selective release of the designed radiometabolite from covalently conjugated polypeptide after lysosomal ...
openaire  

Experimental Evaluation of Proposed Small-Molecule Inhibitors of Water Channel Aquaporin-1. [PDF]

open access: yesMol Pharmacol, 2016
Esteva-Font C   +5 more
europepmc   +1 more source

Renal function in glycogen storage disease type I, natural course, and renopreservative effects of ACE inhibition. [PDF]

open access: yesClin J Am Soc Nephrol, 2009
Martens DH   +5 more
europepmc   +1 more source

Copeptin, a surrogate marker of vasopressin, is associated with disease severity in autosomal dominant polycystic kidney disease. [PDF]

open access: yesClin J Am Soc Nephrol, 2011
Meijer E   +6 more
europepmc   +1 more source

TSPO 18 kDa (PBR) Targeted Photosensitizers for Cancer Imaging (PET) and PDT. [PDF]

open access: yesACS Med Chem Lett, 2011
Chen Y   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy